[1. JALIL SF., ARSHAD M., BHATTI A., AHMAD J., AKBAR F., ALI S., et al. Review -Rheumatoid arthritis: What have we learned about the causing factors? Pak J Pharm Sci. 2016;29(2):629-45.]Search in Google Scholar
[2. LOZA E., LAJAS C., ANDREU JL., BALSA A., GONZALEZ-ALVARO I., ILLERA O., et al. Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis. Rheumatol Int. 2015;35(3):445-58.10.1007/s00296-014-3196-725543267]Search in Google Scholar
[3. TURESSON C., MATHSSON L., JACOBSSON LT., STURFELT G., RÖNNELID J. Antibodies to modified citrullinated vimentin are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis. 2013;72(12):2047-8.10.1136/annrheumdis-2013-20351023740235]Search in Google Scholar
[4. KAPITANY A., ZILAHI E., SZANTO S., SZÜCS G., SZABO Z., VEGVARI A., et al. Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary. Ann N Y Acad Sci. 2005;1051:263-70.10.1196/annals.1361.06716126967]Search in Google Scholar
[5. FOX DA., GIZINSKI A., MORGAN R., LUNDY SK. Cell-cell interactions in rheumatoid arthritis synovium. Rheum Dis Clin North Am. 2010;36(2):311-23.10.1016/j.rdc.2010.02.004287939720510236]Search in Google Scholar
[6. CHIMENTI MS., TRIGGIANESE P., CONIGLIARO P., CANDI E., MELINO G., PERRICONE R. The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Dis. 2015;6:e1887.10.1038/cddis.2015.246465044226379192]Search in Google Scholar
[7. MERRY P., WINYARD PG., MORRIS CJ., GROOTVELD M., BLAKE DR. Oxygen free radicals, inflammation, and synovitis: the current status. Ann Rheum Dis. 1989;48(10):864-70.10.1136/ard.48.10.86410038972684056]Search in Google Scholar
[8. HITCHON CA., EL-GABALAWY HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther. 2004;6(6):265-78.10.1186/ar1447106487415535839]Search in Google Scholar
[9. IÇME F., EREL Ö., AVCI A., SATAR S., GÜLEN M., ACEHAN S. The relation between oxidative stress parameters, ischemic stroke, and hemorrhagic stroke. Turk J Med Sci. 2015;45(4):947-53.10.3906/sag-1402-9626422872]Search in Google Scholar
[10. KUNDI H., ATES I., KIZILTUNC E., CETIN M., CICEKCIOGLU H., NESELIOGLU S., et al. A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasis. Am J Emerg Med. 2015;33(11):1567-71.10.1016/j.ajem.2015.06.01626143314]Search in Google Scholar
[11. KUNDI H., EREL Ö., BALUN A., ÇIÇEKÇIOĞLU H., CETIN M., KIZILTUNÇ E., et al. Association of thiol/disulfide ratio with syntax score in patients with NSTEMI. Scand Cardiovasc J. 2015;49(2):95-100.10.3109/14017431.2015.101315325658436]Search in Google Scholar
[12. EREL O., NESELIOGLU S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47(18):326-32.10.1016/j.clinbiochem.2014.09.02625304913]Search in Google Scholar
[13. VILLENEUVE E., NAM J., EMERY P. 2010 ACR-EULAR classification criteria for rheumatoid arthritis. Rev Bras Reumatol. 2010;50(5):481-3.10.1590/S0482-50042010000500001]Search in Google Scholar
[14. TEKEOĞLU I., HARMAN H., SAĞ S., ALTINDIŞ M., KAMANLI A., NAS K. Levels of serum pentraxin 3, IL-6, fetuin A and insulin in patients with rheumatoid arthritis. Cytokine. 2016;83:171-5.10.1016/j.cyto.2016.04.00927152709]Search in Google Scholar
[15. CURE E., CUMHUR CURE M., TUMKAYA L., KALKAN Y., AYDIN I., KIRBAS A., et al. Adalimumab ameliorates abdominal aorta cross clamping which induced liver injury in rats. Biomed Res Int. 2014;2014:907915.10.1155/2014/907915391432624551855]Search in Google Scholar
[16. JIA Z., HE J. Paeoniflorin ameliorates rheumatoid arthritis in rat models through oxidative stress, inflammation and cyclooxygenase 2. Exp Ther Med. 2016;11(2):655-9.10.3892/etm.2015.2908473402126893662]Search in Google Scholar
[17. CACCIAPAGLIA F., ANELLI MG., RIZZO D., MORELLI E., SCIOSCIA C., MAZZOTTA D., et al. Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients. Reumatismo. 2015;67(3):97-102.10.4081/reumatismo.2015.82926876188]Search in Google Scholar
[18. MATEEN S., MOIN S., KHAN AQ., ZAFAR A., FATIMA N. Increased Reactive Oxygen Species Formation and Oxidative Stress in Rheumatoid Arthritis. Plos One. 2016;11(4):e0152925.10.1371/journal.pone.0152925482027427043143]Search in Google Scholar
[19. FILIPPIN LI., VERCELINO R., MARRONI NP., XAVIER RM. Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol. 2008;152(3):415-22.10.1111/j.1365-2249.2008.03634.x245319618422737]Search in Google Scholar
[20. KALPAKCIOGLU B., SENEL K. The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis. Clin Rheumatol. 2008;27(2):141-5.10.1007/s10067-007-0746-317912575]Search in Google Scholar
[21. ALTINDAG O., KARAKOC M., KOCYIGIT A., CELIK H., SORAN N. Increased DNA damage and oxidative stress in patients with rheumatoid arthritis. Clin Biochem. 2007;40(3-4):167-71.10.1016/j.clinbiochem.2006.10.00617196579]Search in Google Scholar
[22. EL-BANNA H., JIMAN-FATANI A. Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis. BMC Musculoskelet Disord. 2014;15:379.10.1186/1471-2474-15-379]Search in Google Scholar
[23. NAKAJIMA A., AOKI Y., SHIBATA Y., SONOBE M., TERAJIMA F., TAKAHASHI H., et al. Identification of clinical parameters associated with serum oxidative stress in patients with rheumatoid arthritis. Mod Rheumatol. 2014;24(6):926-30.10.3109/14397595.2014.891495]Search in Google Scholar
[24. HIRAO M., YAMASAKI N., OZE H., EBINA K., NAMPEI A., KAWATO Y., et al. Serum level of oxidative stress marker is dramatically low in patients with rheumatoid arthritis treated with tocilizumab. Rheumatol Int. 2012;32(12):4041-5.10.1007/s00296-011-2135-0]Search in Google Scholar
[25. MORALES K., OLESEN MN., POULSEN ET., LARSEN UG., ENGHILD JJ., PETERSEN SV. The effects of hypochlorous acid and neutrophil proteases on the structure and function of extracellular superoxide dismutase. Free Radic Biol Med. 2015;81:38-46.10.1016/j.freeradbiomed.2014.12.027]Search in Google Scholar
[26. AOYAMA K., NAKAKI T. Glutathione in Cellular Redox Homeostasis: Association with the Excitatory Amino Acid Carrier 1 (EAAC1). Molecules. 2015;20(5):8742-58.10.3390/molecules20058742]Search in Google Scholar
[27. NAGY P. Kinetics and mechanisms of thiol-disulfide exchange covering direct substitution and thiol oxidation-mediated pathways. Antioxid Redox Signal. 2013;18(13):1623-41.10.1089/ars.2012.4973]Search in Google Scholar
[28. TURELL L., CARBALLAL S., BOTTI H., RADI R., ALVAREZ B. Oxidation of the albümin thiol to sulfenic acid and its implications in the intravascular compartment. Braz J Med Biol Res. 2009;42(4):305-11.10.1590/S0100-879X2009000400001]Search in Google Scholar
[29. ELLMAN G., LYSKO H. A precise method for the determination of whole blood and plasma sulfhydryl groups. Anal Biochem. 1979;93(1):98-102.10.1016/S0003-2697(79)80122-0]Search in Google Scholar
[30. YUCEL A., SANHAL CY., DAGLAR K., KARA O., UYGUR D., EREL O. Thiol/disulphide homeostasis in pregnant women with Familial Mediterranean fever. Redox Rep. 2016;21(6):287-91.10.1080/13510002.2016.1168590683768027077456]Search in Google Scholar
[31. ATES I., OZKAYAR N., INAN B., YILMAZ FM., TOPCUOGLU C., NESELIOGLU S., et al. Dynamic thiol/disulphide homeostasis in patients with newly diagnosed primary hypertension. J Am Soc Hypertens. 2016;10(2):159-66.10.1016/j.jash.2015.12.00826725016]Search in Google Scholar
[32. ATES I., KAPLAN M., YUKSEL M., MESE D., ALISIK M., EREL Ö., et al. Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine. 2016;51(1):47-51.10.1007/s12020-015-0784-626547218]Search in Google Scholar
[33. CHEN Z., MA T., HUANG C., ZHANG L., HU T., LI J. MIF, a potential therapeutic target for rheumatoid arthritis? Rheumatol Int. 2014;34(10):1481-2.10.1007/s00296-013-2877-y24463567]Search in Google Scholar
[34. GIUSTARINI D., LORENZINI S., ROSSI R., CHINDAMO D., DI SIMPLICIO P., MARCOLONGO R. Altered thiol pattern in plasma of subjects affected by rheumatoid arthritis. Clin Exp Rheumatol. 2005;23(2):205-12.]Search in Google Scholar
[35. POPA C., VAN TITS LJ., BARRERA P., LEMMERS HL., VAN DEN HOOGEN FH., VAN RIEL PL., et al. Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients. Ann Rheum Dis. 2009;68(6):868-72.10.1136/ard.2008.09217118635596]Search in Google Scholar
[36. HEIDARI R., TAHERI V., RAHIMI HR., SHIRAZI YEGANEH B., NIKNAHAD H., NAJIBI A. Sulfasalazine-induced renal injury in rats and the protective role of thiol-reductants. Ren Fail. 2016;38(1):137-41.10.3109/0886022X.2015.109673126479898]Search in Google Scholar